ENDRA Life Sciences Inc (NAS:NDRA)
$ 0.1389 0.0539 (63.41%) Market Cap: 1.52 Mil Enterprise Value: 117,000.00 PE Ratio: 0 PB Ratio: 0.41 GF Score: 0/100

Q4 2020 ENDRA Life Sciences Inc Earnings Call Transcript

Mar 25, 2021 / 08:30PM GMT
Release Date Price: $46.2
Operator

Good afternoon, ladies and gentlemen, and welcome to the ENDRA Life Sciences, Inc. fourth-quarter 2020 financial results conference call. (Operator Instructions) It is now my pleasure to turn the floor over to your host, Yvonne Briggs. Ma'am, the floor is yours.

Yvonne Briggs
LHA Investor Relations - IR

Thank you, operator. This is Yvonne Briggs with LHA, ENDRA Life Sciences' Investor Relations firm.

Good afternoon, and welcome to ENDRA's fourth-quarter 2020 business update and financial results conference call. Earlier today, ENDRA issued a press release on this topic and for those of you who don't have a copy, you can access it in the Investors section of ENDRA's website at endrainc.com.

Before we begin, please note that today's discussion will include forward-looking statements. All statements other than statements of historical facts, including statements regarding the company's strategies, financial condition, operations, costs, plans, and objectives, as well as anticipated results of development and commercialization efforts, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot